Search Ontology: 
        
        ChEBI
            dactolisib
- Term ID
 - CHEBI:71952
 - Synonyms
 - 
    
        
        
- 2-methyl-2-{4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl]phenyl}propanenitrile
 - BEZ 235
 - BEZ-235
 - BEZ235
 - NVP BEZ235
 - NVP-BEZ 235
 - NVP-BEZ235
 - NVPBEZ235
 
 - Definition
 - An imidazoquinoline that is 3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]quinoline substituted at position 1 by a 4-(1-cyanoisopropyl)phenyl group and at position 8 by a quinolin-3-yl group. A dual PI3K/mTOR inhibitor used in cancer treatment.
 - References
 - 
    
        
        
    
    
- CAS:915019-65-7
 - LINCS:LSM-4255
 - PMID:22020918
 - PMID:22154651
 - PMID:22218692
 - PMID:22287733
 - PMID:22299028
 - PMID:22355272
 - PMID:22401294
 - PMID:22415236
 - PMID:22452803
 - PMID:22560334
 - PMID:22662154
 - PMID:22727754
 - PMID:22858987
 - PMID:22895065
 - PMID:22920938
 - PMID:22960230
 - PMID:22989521
 - PMID:23077520
 - PMID:23215722
 - PMID:23232026
 - PMID:23300274
 - PMID:23319394
 - PMID:23319457
 - PMID:23321494
 - PMID:23343422
 - Patent:WO2006122806
 - Patent:WO2008064093
 - Reaxys:12748665
 
 - Ontology
 - ChEBI ( EBI )
 
                
                    
                        Phenotype 
                    
                    
                
                
            
        
        
    
        
            
            
    
    
    
    
                
                    
                        Phenotype resulting from dactolisib
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype where environments contain dactolisib
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype modified by environments containing dactolisib
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype affecting dactolisib
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Human Disease Model